Bu-Hai Wang (Buhai Wang)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Technology in cancer research & treatment

Cancer medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yichun Zeng, Liying Zhang, Yichen Liang, Xian Zhang, Lei Li, Maoqi Wang, Jingliang Guo, Qiuxian Li, Jin Cao, Juan J Gu, Bu-Hai Wang
Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non-small cell lung cancer patients with recurrence or metastasis: A systematic review and meta-analysis. Cancer medicine (2023)
Bu-Hai Wang, Shiwei Fu, Yuxiang Huang, Liqin Liu, Yichen Liang, Wenxian An, Yaqin Fan, Yisa Zhao
The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis. Technology in cancer research & treatment 20 (2022)
Si-Yang Liu, Hua Bao, Qun Wang, Wei-Min Mao, Yuchen Han, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang W Shao, Wen-Zhao Zhong, Yi-Long Wu
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes. Nature communications 12 (1) (2021)